Risk stratification and clinical outcomes after pulmonary valve replacement

Back

ESC Premium Access

Risk stratification and clinical outcomes after pulmonary valve replacement

Session: Risk stratification in congenital heart disease

Topic: Diagnostic Methods

Speaker: Doctor A. Egbe (Rochester, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Egbe

Mayo Clinic, Rochester (United States of America)

1 presentation

1 follower

7 more presentations in this session

Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study

Speaker: Ms A. van Dissel (Amsterdam, NL)

Access

Abstract

Development and validation of a risk prediction model in patients with adult congenital heart disease

Speaker: Ms V. Baggen (Rotterdam, NL)

Prognostic value of echocardiographic and blood biomarkers in patients with a systemic right ventricle

Speaker: Doctor A. Van Den Bosch (Rotterdam, NL)

Predictors of mortality following hospitalisation in adults with congenital heart disease

Speaker: Doctor A. Khokhar (London, GB)

Prognostic value of left ventricular rotation and strain in adult patients with repaired tetralogy of Fallot

Speaker: Mr R. van Grootel (Rotterdam, NL)

Access the full session

Risk stratification in congenital heart disease

Speakers: Doctor A. Egbe, Ms A. van Dissel, Ms V. Baggen, Doctor A. Van Den Bosch, Doctor A. Khokhar...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources